| Display title | Medicine:Epstein–Barr virus vaccine |
| Default sort key | Epstein-Barr virus vaccine |
| Page length (in bytes) | 10,698 |
| Namespace ID | 3048 |
| Namespace | Medicine |
| Page ID | 519087 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>S.Timg |
| Date of page creation | 01:19, 5 February 2024 |
| Latest editor | imported>S.Timg |
| Date of latest edit | 01:19, 5 February 2024 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | (As of 2024), a vaccine against Epstein–Barr virus was not yet available. The virus establishes latent infection and causes infectious mononucleosis. There is also increasingly more evidence that EBV may be a trigger of multiple sclerosis. It is a dual-tropic virus, meaning that it infects two different... |
